Thelansis’s "Antimicrobial Resistance (AMR) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Antimicrobial Resistance treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Antimicrobial Resistance is a global health crisis wherein pathogens acquire genetic mechanisms, including enzymatic drug inactivation, efflux pumps, and target modification, rendering standard antibiotics ineffective. It manifests as treatment-refractory infections with persistent fever, systemic inflammation, and organ dysfunction. Diagnosis integrates culture with MIC testing alongside rapid molecular PCR panels and metagenomic sequencing to identify resistance genes such as blaKPC and blaNDM within hours. Management deploys pathogen-directed last-resort agents including ceftazidime-avibactam, meropenem-vaborbactam, and cefiderocol, guided by stewardship principles. Serial cultures and inflammatory markers monitor response. Pan-resistant infections warrant immediate infectious disease specialist involvement and combination salvage strategies.
G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)
*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.
1. Key Findings and Analyst Commentary
2. Disease Context
3. Epidemiology
4. Market Size and Forecast
5. Competitive Landscape
6. Unmet Need and TPP Analysis
7. Regulatory and Reimbursement Environments (by country and payer insights)
8. Appendix (e.g., bibliography, methodology)
No snapshots available.
That depends on the file type you choose: the Excel epidemiology model, the Excel market forecast model with dashboard, and the full analyst report in PowerPoint with a PDF version.
Within 48 to 72 hours of purchase.
Yes. Choose EU5, G7 or G8, or pick individual markets in the panel.
Yes. Request a free sample to preview the scope and sample pages.
Yes. The forecast model is customizable, and our analysts can tailor the scope to your questions.
Yes. Inquire for bundle discounted pricing and we will send you exclusive pricing for the reports you need.
Choose the file type you want to purchase or request.
No file type found.
Select markets to include.
No markets match your search.
Not sure which report fits your question? Our team will point you to the right one.
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
Prefer to talk it through? Email clientsupport@thelansis.com
You asked for for covering . We will reply to .
Fill in your details and our expert consultants will get in touch with you.
Get a sneak peek at the latest Antimicrobial Resistance (AMR) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035 report
Our team will get in touch with you shortly about the Antimicrobial Resistance (AMR) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035 report.